| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 440.1K | $19.61M | -64,000 | |
| Other | 138.6K | $6.17M | -7,215 | |
| Other | 123.1K | $5.48M | - | |
| CFO | 116.9K | $5.21M | -8,262 | |
| Other | 111.5K | $4.97M | -8,233 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | Rote William E.58 | Chief Research Officer | Sale+OE | 3,198 | $21.05 | $67,317.90 | -3.1% | -25.5% | +109.2% | |
| May 5, 2025 | Reed Elizabeth E58 | Chief Legal Officer And GC | Sale+OE | 4,920 | $21.05 | $103,566.00 | -5.2% | -25.5% | +109.2% | |
| May 5, 2025 | Cline Christopher R.50 | Chief Financial Officer | Sale+OE | 1,784 | $21.05 | $37,553.20 | -1.9% | -25.5% | +109.2% | |
| Apr 11, 2025 | Cline Christopher R.50 | Chief Financial Officer | Sell | 48 | $13.14 | $630.94 | - | +14.1% | +99.7% | |
| Feb 12, 2025 | Inrig Jula45 | Chief Medical Officer | Sale+OE | 2,568 | $23.53 | $60,425.55 | -2.8% | -9.7% | +31.9% | |
| Feb 12, 2025 | Rote William E.58 | Senior Vice President, R&D | Sale+OE | 5,200 | $23.53 | $122,356.00 | -5.0% | -9.7% | +31.9% | |
| Feb 12, 2025 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sale+OE | 8,000 | $23.53 | $188,240.00 | -8.2% | -9.7% | +31.9% | |
| Feb 12, 2025 | Heerma Peter53 | Chief Commercial Officer | Sale+OE | 5,642 | $24.33 | $137,275.55 | -2.2% | -9.7% | +31.9% | |
| Feb 11, 2025 | Calvin Sandra60 | SVP, Chief Accounting Officer | Sale+OE | 54,244 | $25.00 | $1,356,100.00 | -14.9% | -9.3% | +27.2% | |
| Feb 11, 2025 | Dube Eric M57 | Chief Executive Officer | Sell | 11,375 | $24.04 | $273,455.00 | -2.6% | -9.3% | +27.2% |